{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:02:58Z","timestamp":1779667378735,"version":"3.53.1"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T00:00:00Z","timestamp":1775433600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"vor","delay-in-days":49,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-026-04310-8","type":"journal-article","created":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T03:49:26Z","timestamp":1775447366000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeted hyperthermia therapy (THT) using gold nanorods remodels the tumor microenvironment to sensitize murine microsatellite-stable colorectal cancer to immune checkpoint blockade"],"prefix":"10.1186","volume":"24","author":[{"given":"Barry E.","family":"Kennedy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie L.","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geetha","family":"Subramanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate N.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl","family":"Dean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas P.","family":"Cheverie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly J.","family":"Corscadden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin","family":"Gormley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin B.","family":"Noftall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark R.","family":"Hanes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Edgar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean S.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carman A.","family":"Giacomantonio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,6]]},"reference":[{"issue":"3","key":"4310_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"4310_CR2","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1136\/gutjnl-2022-327736","volume":"72","author":"E Morgan","year":"2023","unstructured":"Morgan E, Arnold M, Gini A, Lorenzoni V, Cabasag CJ, Laversanne M, et al. Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN. Gut. 2023;72(2):338\u201344. https:\/\/doi.org\/10.1136\/gutjnl-2022-327736.","journal-title":"Gut"},{"issue":"2","key":"4310_CR3","doi-asserted-by":"publisher","first-page":"519","DOI":"10.3748\/wjg.v22.i2.519","volume":"22","author":"G Brandi","year":"2016","unstructured":"Brandi G. Adjuvant chemotherapy for resected colorectal cancer metastases: literature review and meta-analysis. WJG. 2016;22(2):519. https:\/\/doi.org\/10.3748\/wjg.v22.i2.519.","journal-title":"WJG"},{"issue":"1","key":"4310_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-020-07656-w","volume":"20","author":"H Rumpold","year":"2020","unstructured":"Rumpold H, Nieders\u00fc\u00df-Beke D, Heiler C, Falch D, Wundsam HV, Metz-Gercek S, et al. Prediction of mortality in metastatic colorectal cancer in a real-life population: a multicenter explorative analysis. BMC Cancer. 2020;20(1):1149. https:\/\/doi.org\/10.1186\/s12885-020-07656-w.","journal-title":"BMC Cancer"},{"issue":"4","key":"4310_CR5","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.tips.2023.01.003","volume":"44","author":"AE Shin","year":"2023","unstructured":"Shin AE, Giancotti FG, Rustgi AK. Metastatic colorectal cancer: mechanisms and emerging therapeutics. Trends Pharmacol Sci. 2023;44(4):222\u201336. https:\/\/doi.org\/10.1016\/j.tips.2023.01.003.","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"4310_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01953-7","volume":"9","author":"Q Li","year":"2024","unstructured":"Li Q, Geng S, Luo H, Wang W, Mo YQ, Luo Q, et al. Signaling pathways involved in colorectal cancer: pathogenesis and targeted therapy. Signal Transduct Target Ther. 2024;9(1):266. https:\/\/doi.org\/10.1038\/s41392-024-01953-7.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"4310_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-60255-4","volume":"10","author":"GE Idos","year":"2020","unstructured":"Idos GE, Kwok J, Bonthala N, Kysh L, Gruber SB, Qu C. The prognostic implications of tumor infiltrating lymphocytes in colorectal cancer: a systematic review and meta-analysis. Sci Rep. 2020;10(1):3360. https:\/\/doi.org\/10.1038\/s41598-020-60255-4.","journal-title":"Sci Rep"},{"issue":"3","key":"4310_CR8","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3322\/caac.21448","volume":"68","author":"PM Boland","year":"2018","unstructured":"Boland PM, Yurgelun MB, Boland CR. Recent progress in Lynch syndrome and other familial colorectal cancer syndromes. CA Cancer J Clin. 2018;68(3):217\u201331. https:\/\/doi.org\/10.3322\/caac.21448.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"4310_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-023-01274-z","volume":"24","author":"K Mortezaee","year":"2024","unstructured":"Mortezaee K. WNT\/\u03b2-catenin regulatory roles on PD-(L)1 and immunotherapy responses. Clin Exp Med. 2024;24(1):15. https:\/\/doi.org\/10.1007\/s10238-023-01274-z.","journal-title":"Clin Exp Med"},{"issue":"1","key":"4310_CR10","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1053\/j.gastro.2016.10.015","volume":"152","author":"B Jung","year":"2017","unstructured":"Jung B, Staudacher JJ, Beauchamp D. Transforming growth factor \u03b2 superfamily signaling in development of colorectal cancer. Gastroenterology. 2017;152(1):36\u201352. https:\/\/doi.org\/10.1053\/j.gastro.2016.10.015.","journal-title":"Gastroenterology"},{"issue":"4","key":"4310_CR11","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1089\/jir.2014.0132","volume":"35","author":"L Wang","year":"2015","unstructured":"Wang L, Wang Y, Song Z, Chu J, Qu X. Deficiency of interferon-gamma or its receptor promotes colorectal cancer development. J Interferon Cytokine Res. 2015;35(4):273\u201380. https:\/\/doi.org\/10.1089\/jir.2014.0132.","journal-title":"J Interferon Cytokine Res"},{"issue":"10","key":"4310_CR12","doi-asserted-by":"publisher","first-page":"3074","DOI":"10.1158\/1078-0432.CCR-18-1942","volume":"25","author":"JJ Luke","year":"2019","unstructured":"Luke JJ, Bao R, Sweis RF, Spranger S, Gajewski TF. WNT\/\u03b2-catenin pathway activation correlates with immune exclusion across human cancers. Clin Cancer Res. 2019;25(10):3074\u201383. https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-1942.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"4310_CR13","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1158\/2159-8290.CD-14-0863","volume":"5","author":"NJ Llosa","year":"2015","unstructured":"Llosa NJ, Cruise M, Tam A, Wicks EC, Hechenbleikner EM, Taube JM, et al. The vigorous immune microenvironment of microsatellite instable colon cancer is balanced by multiple counter-inhibitory checkpoints. Cancer Discov. 2015;5(1):43\u201351. https:\/\/doi.org\/10.1158\/2159-8290.CD-14-0863.","journal-title":"Cancer Discov"},{"issue":"1","key":"4310_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-15-190","volume":"15","author":"JC Castle","year":"2014","unstructured":"Castle JC, Loewer M, Boegel S, De Graaf J, Bender C, Tadmor AD, et al. Immunomic, genomic and transcriptomic characterization of CT26 colorectal carcinoma. BMC Genomics. 2014;15(1):190. https:\/\/doi.org\/10.1186\/1471-2164-15-190.","journal-title":"BMC Genomics"},{"issue":"1","key":"4310_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22033-2","volume":"12","author":"K Alicea-Torres","year":"2021","unstructured":"Alicea-Torres K, Sanseviero E, Gui J, Chen J, Veglia F, Yu Q, et al. Immune suppressive activity of myeloid-derived suppressor cells in cancer requires inactivation of the type I interferon pathway. Nat Commun. 2021;12(1):1717. https:\/\/doi.org\/10.1038\/s41467-021-22033-2.","journal-title":"Nat Commun"},{"issue":"14","key":"4310_CR16","doi-asserted-by":"publisher","first-page":"12369","DOI":"10.18632\/oncotarget.3682","volume":"6","author":"I Dufait","year":"2015","unstructured":"Dufait I, Schwarze JK, Liechtenstein T, Leonard W, Jiang H, Escors D, et al. Ex vivo generation of myeloid-derived suppressor cells that model the tumor immunosuppressive environment in colorectal cancer. Oncotarget. 2015;6(14):12369\u201382. https:\/\/doi.org\/10.18632\/oncotarget.3682.","journal-title":"Oncotarget"},{"issue":"9","key":"4310_CR17","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1097\/01.cji.0000436722.46675.4a","volume":"36","author":"MG Lechner","year":"2013","unstructured":"Lechner MG, Karimi SS, Barry-Holson K, Angell TE, Murphy KA, Church CH, et al. Immunogenicity of murine solid tumor models as a defining feature of in vivo behavior and response to immunotherapy. J Immunother. 2013;36(9):477\u201389. https:\/\/doi.org\/10.1097\/01.cji.0000436722.46675.4a.","journal-title":"J Immunother"},{"issue":"2","key":"4310_CR18","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.trecan.2024.11.009","volume":"11","author":"T Isermann","year":"2025","unstructured":"Isermann T, Sers C, Der CJ, Papke B. KRAS inhibitors: resistance drivers and combinatorial strategies. Trends Cancer. 2025;11(2):91\u2013116. https:\/\/doi.org\/10.1016\/j.trecan.2024.11.009.","journal-title":"Trends Cancer"},{"issue":"1","key":"4310_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-08101-1","volume":"16","author":"L Tian","year":"2025","unstructured":"Tian L, Li H, Cui H, Tang C, Zhao P, Wang X, et al. Oncogenic KRAS mutations drive immune suppression through immune-related regulatory network and metabolic reprogramming. Cell Death Dis. 2025;16(1):785. https:\/\/doi.org\/10.1038\/s41419-025-08101-1.","journal-title":"Cell Death Dis"},{"issue":"11","key":"4310_CR20","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.humimm.2011.07.312","volume":"72","author":"P Koci\u00e1n","year":"2011","unstructured":"Koci\u00e1n P, \u0160edivcov\u00e1 M, Drg\u00e1\u010d J, \u010cern\u00e1 K, Hoch J, Kodet R, et al. Tumor-infiltrating lymphocytes and dendritic cells in human colorectal cancer: their relationship to KRAS mutational status and disease recurrence. Hum Immunol. 2011;72(11):1022\u20138. https:\/\/doi.org\/10.1016\/j.humimm.2011.07.312.","journal-title":"Hum Immunol"},{"issue":"6","key":"4310_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202203757","volume":"10","author":"H Liu","year":"2023","unstructured":"Liu H, Liang Z, Cheng S, Huang L, Li W, Zhou C, et al. Mutant KRAS drives immune evasion by sensitizing cytotoxic T-cells to activation\u2010induced cell death in colorectal cancer. Adv Sci. 2023;10(6):2203757. https:\/\/doi.org\/10.1002\/advs.202203757.","journal-title":"Adv Sci"},{"issue":"15","key":"4310_CR22","doi-asserted-by":"publisher","first-page":"7546","DOI":"10.7150\/thno.56482","volume":"11","author":"X Huang","year":"2021","unstructured":"Huang X, Lu Y, Guo M, Du S, Han N. Recent strategies for nano-based PTT combined with immunotherapy: from a biomaterial point of view. Theranostics. 2021;11(15):7546\u201369. https:\/\/doi.org\/10.7150\/thno.56482.","journal-title":"Theranostics"},{"issue":"3","key":"4310_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16030505","volume":"16","author":"T Logghe","year":"2024","unstructured":"Logghe T, Van Zwol E, Immordino B, Van Den Cruys K, Peeters M, Giovannetti E, et al. Hyperthermia in combination with emerging targeted and immunotherapies as a new approach in cancer treatment. Cancers. 2024;16(3):505. https:\/\/doi.org\/10.3390\/cancers16030505.","journal-title":"Cancers"},{"issue":"5","key":"4310_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/cancers8050049","volume":"8","author":"M Bordonaro","year":"2016","unstructured":"Bordonaro M, Shirasawa S, Lazarova D. In hyperthermia increased ERK and WNT signaling suppress colorectal cancer cell growth. Cancers. 2016;8(5):49. https:\/\/doi.org\/10.3390\/cancers8050049.","journal-title":"Cancers"},{"issue":"6","key":"4310_CR25","doi-asserted-by":"publisher","first-page":"591","DOI":"10.3109\/02656736.2011.589234","volume":"27","author":"I Knippertz","year":"2011","unstructured":"Knippertz I, Stein M, D\u00f6rrie J, Schaft N, M\u00fcller I, Deinzer A, et al. Mild hyperthermia enhances human monocyte-derived dendritic cell functions and offers potential for applications in vaccination strategies. Int J Hyperth. 2011;27(6):591\u2013603. https:\/\/doi.org\/10.3109\/02656736.2011.589234.","journal-title":"Int J Hyperth"},{"issue":"5","key":"4310_CR26","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1007\/s00262-020-02751-0","volume":"70","author":"R Kleef","year":"2021","unstructured":"Kleef R, Nagy R, Baierl A, Bacher V, Bojar H, McKee DL, et al. Low-dose ipilimumab plus nivolumab combined with IL-2 and hyperthermia in cancer patients with advanced disease: exploratory findings of a case series of 131 stage IV cancers \u2013 a retrospective study of a single institution. Cancer Immunol Immunother. 2021;70(5):1393\u2013403. https:\/\/doi.org\/10.1007\/s00262-020-02751-0.","journal-title":"Cancer Immunol Immunother"},{"issue":"1","key":"4310_CR27","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1080\/02656736.2020.1868582","volume":"38","author":"IU Khan","year":"2021","unstructured":"Khan IU, Brooks G, Guo NN, Chen J, Guo F. Fever-range hyperthermia promotes cGAS-STING pathway and synergizes DMXAA-induced antiviral immunity. Int J Hyperthermia. 2021;38(1):30\u20137. https:\/\/doi.org\/10.1080\/02656736.2020.1868582.","journal-title":"Int J Hyperthermia"},{"key":"4310_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.865554","volume":"13","author":"XY Chen","year":"2022","unstructured":"Chen XY, Yung LYL, Tan PH, Bay BH. Harnessing the immunogenic potential of gold nanoparticle-based platforms as a therapeutic strategy in breast cancer immunotherapy: a mini review. Front Immunol. 2022;13:865554. https:\/\/doi.org\/10.3389\/fimmu.2022.865554.","journal-title":"Front Immunol"},{"key":"4310_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1512543","volume":"15","author":"BE Kennedy","year":"2025","unstructured":"Kennedy BE, Noftall EB, Dean C, Roth A, Clark KN, Rowles D, et al. Targeted intra-tumoral hyperthermia using uniquely biocompatible gold nanorods induces strong immunogenic cell death in two immunogenically \u2018cold\u2019 tumor models. Front Immunol. 2025;15:1512543. https:\/\/doi.org\/10.3389\/fimmu.2024.1512543.","journal-title":"Front Immunol"},{"issue":"8","key":"4310_CR30","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1007\/s00330-013-2825-y","volume":"23","author":"GC Van Rhoon","year":"2013","unstructured":"Van Rhoon GC, Samaras T, Yarmolenko PS, Dewhirst MW, Neufeld E, Kuster N. CEM43\u00b0C thermal dose thresholds: a potential guide for magnetic resonance radiofrequency exposure levels? Eur Radiol. 2013;23(8):2215\u201327. https:\/\/doi.org\/10.1007\/s00330-013-2825-y.","journal-title":"Eur Radiol"},{"issue":"1","key":"4310_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-00491-8","volume":"15","author":"RO Betschart","year":"2025","unstructured":"Betschart RO, Thal\u00e9n F, Blankenberg S, Zoche M, Zeller T, Ziegler A. A benchmark study of compression software for human short-read sequence data. Sci Rep. 2025;15(1):15358. https:\/\/doi.org\/10.1038\/s41598-025-00491-8.","journal-title":"Sci Rep"},{"issue":"1","key":"4310_CR32","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29(1):15\u201321. https:\/\/doi.org\/10.1093\/bioinformatics\/bts635.","journal-title":"Bioinformatics"},{"issue":"10","key":"4310_CR33","doi-asserted-by":"publisher","DOI":"10.1093\/g3journal\/jkad188","volume":"13","author":"E Schmid-Siegert","year":"2023","unstructured":"Schmid-Siegert E, Qin M, Tian H, Arpat B, Chen B, Xenarios I. Reference genomes for BALB\/c Nude and NOD\/SCID mouse models. G3: Genes, Genomes, Genetics. 2023;13(10):jkad188. https:\/\/doi.org\/10.1093\/g3journal\/jkad188.","journal-title":"G3: Genes, Genomes, Genetics"},{"issue":"16","key":"4310_CR34","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, et al. The sequence alignment\/map format and SAMtools. Bioinformatics. 2009;25(16):2078\u20139. https:\/\/doi.org\/10.1093\/bioinformatics\/btp352.","journal-title":"Bioinformatics"},{"issue":"7","key":"4310_CR35","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","volume":"30","author":"Y Liao","year":"2014","unstructured":"Liao Y, Smyth GK, Shi W. FeatureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics. 2014;30(7):923\u201330. https:\/\/doi.org\/10.1093\/bioinformatics\/btt656.","journal-title":"Bioinformatics"},{"issue":"1","key":"4310_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-018-2486-6","volume":"19","author":"SX Ge","year":"2018","unstructured":"Ge SX, Son EW, Yao R. IDEP: an integrated web application for differential expression and pathway analysis of RNA-seq data. BMC Bioinformatics. 2018;19(1):534. https:\/\/doi.org\/10.1186\/s12859-018-2486-6.","journal-title":"BMC Bioinformatics"},{"issue":"3","key":"4310_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/cpz1.90","volume":"1","author":"Z Xie","year":"2021","unstructured":"Xie Z, Bailey A, Kuleshov MV, Clarke DJB, Evangelista JE, Jenkins SL, et al. Gene set knowledge discovery with Enrichr. Curr Protoc. 2021;1(3):e90. https:\/\/doi.org\/10.1002\/cpz1.90.","journal-title":"Curr Protoc"},{"issue":"5","key":"4310_CR38","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/nmeth.3364","volume":"12","author":"DA Bolotin","year":"2015","unstructured":"Bolotin DA, Poslavsky S, Mitrophanov I, Shugay M, Mamedov IZ, Putintseva EV, et al. MiXCR: software for comprehensive adaptive immunity profiling. Nat Methods. 2015;12(5):380\u20131. https:\/\/doi.org\/10.1038\/nmeth.3364.","journal-title":"Nat Methods"},{"issue":"4","key":"4310_CR39","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2009\u2013 \u2206\u2206CT method. Methods. 2001;25(4):402\u20138. https:\/\/doi.org\/10.1006\/meth.2001.1262.","journal-title":"Methods"},{"issue":"3","key":"4310_CR40","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1080\/0265673031000119006","volume":"19","author":"MW Dewhirst","year":"2003","unstructured":"Dewhirst MW, Viglianti BL, Lora-Michiels M, Hanson M, Hoopes PJ. Basic principles of thermal dosimetry and thermal thresholds for tissue damage from hyperthermia. Int J Hyperthermia. 2003;19(3):267\u201394. https:\/\/doi.org\/10.1080\/0265673031000119006.","journal-title":"Int J Hyperthermia"},{"issue":"3","key":"4310_CR41","doi-asserted-by":"publisher","first-page":"256","DOI":"10.3109\/02656730903453546","volume":"26","author":"RJ Griffin","year":"2010","unstructured":"Griffin RJ, Dings RPM, Jamshidi-Parsian A, Song CW. Mild temperature hyperthermia and radiation therapy: role of tumour vascular thermotolerance and relevant physiological factors. Int J Hyperthermia. 2010;26(3):256\u201363. https:\/\/doi.org\/10.3109\/02656730903453546.","journal-title":"Int J Hyperthermia"},{"key":"4310_CR42","doi-asserted-by":"publisher","first-page":"5369","DOI":"10.2147\/IJN.S205409","volume":"14","author":"M Sim\u00f3n","year":"2019","unstructured":"Sim\u00f3n M, N\u00f8rregaard K, J\u00f8rgensen JT, Oddershede LB, Kjaer A. Fractionated photothermal therapy in a murine tumor model: comparison with single dose. IJN. 2019;14:5369\u201379. https:\/\/doi.org\/10.2147\/IJN.S205409.","journal-title":"IJN"},{"issue":"29","key":"4310_CR43","doi-asserted-by":"publisher","first-page":"26861","DOI":"10.18632\/oncotarget.4766","volume":"6","author":"CC Wu","year":"2015","unstructured":"Wu CC, Yang YC, Hsu YT, Wu TC, Hung CF, Huang JT, et al. Nanoparticle-induced intraperitoneal hyperthermia and targeted photoablation in treating ovarian cancer. Oncotarget. 2015;6(29):26861\u201375. https:\/\/doi.org\/10.18632\/oncotarget.4766.","journal-title":"Oncotarget"},{"key":"4310_CR44","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.biomaterials.2015.03.060","volume":"56","author":"CW Hsiao","year":"2015","unstructured":"Hsiao CW, Chuang EY, Chen HL, Wan D, Korupalli C, Liao ZX, et al. Photothermal tumor ablation in mice with repeated therapy sessions using NIR-absorbing micellar hydrogels formed in situ. Biomaterials. 2015;56:26\u201335. https:\/\/doi.org\/10.1016\/j.biomaterials.2015.03.060.","journal-title":"Biomaterials"},{"issue":"8","key":"4310_CR45","doi-asserted-by":"publisher","first-page":"610","DOI":"10.3109\/02656730903315831","volume":"25","author":"T Torigoe","year":"2009","unstructured":"Torigoe T, Tamura Y, Sato N. Heat shock proteins and immunity: application of hyperthermia for immunomodulation. Int J Hyperthermia. 2009;25(8):610\u20136. https:\/\/doi.org\/10.3109\/02656730903315831.","journal-title":"Int J Hyperthermia"},{"issue":"1","key":"4310_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s12865-025-00716-5","volume":"26","author":"S Salman","year":"2025","unstructured":"Salman S, Khalil SM, Abdel-Latif AM, El Attar YA, Salem ML. Induction of high numbers of Treg cells post treatment with anti-IL-2\/IL-2 complex associates with alleviation of experimental psoriasis-like skin inflammation. BMC Immunol. 2025;26(1):94. https:\/\/doi.org\/10.1186\/s12865-025-00716-5.","journal-title":"BMC Immunol"},{"key":"4310_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.595207","volume":"11","author":"Z Li","year":"2020","unstructured":"Li Z, Deng J, Sun J, Ma Y. Hyperthermia targeting the tumor microenvironment facilitates immune checkpoint inhibitors. Front Immunol. 2020;11:595207. https:\/\/doi.org\/10.3389\/fimmu.2020.595207.","journal-title":"Front Immunol"},{"issue":"1","key":"4310_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-89740-0","volume":"11","author":"WFA Wan Mohd Zawawi","year":"2021","unstructured":"Wan Mohd Zawawi WFA, Hibma MH, Salim MI, Jemon K. Hyperthermia by near infrared radiation induced immune cells activation and infiltration in breast tumor. Sci Rep. 2021;11(1):10278. https:\/\/doi.org\/10.1038\/s41598-021-89740-0.","journal-title":"Sci Rep"},{"issue":"1","key":"4310_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12771-9","volume":"10","author":"L Huang","year":"2019","unstructured":"Huang L, Li Y, Du Y, Zhang Y, Wang X, Ding Y, et al. Mild photothermal therapy potentiates anti-PD-L1 treatment for immunologically cold tumors via an all-in-one and all-in-control strategy. Nat Commun. 2019;10(1):4871. https:\/\/doi.org\/10.1038\/s41467-019-12771-9.","journal-title":"Nat Commun"},{"issue":"1","key":"4310_CR50","doi-asserted-by":"publisher","first-page":"77","DOI":"10.2217\/nnm-2019-0190","volume":"15","author":"H Chen","year":"2020","unstructured":"Chen H, Luan X, Paholak HJ, Burnett JP, Stevers NO, Sansanaphongpricha K, et al. Depleting tumor-associated Tregs via nanoparticle-mediated hyperthermia to enhance anti-CTLA-4 immunotherapy. Nanomedicine (Lond). 2020;15(1):77\u201392. https:\/\/doi.org\/10.2217\/nnm-2019-0190.","journal-title":"Nanomedicine (Lond)"},{"key":"4310_CR51","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.686548","volume":"9","author":"X Wu","year":"2021","unstructured":"Wu X, Sun M, Yang Z, Lu C, Wang Q, Wang H, et al. The roles of CCR9\/CCL25 in inflammation and inflammation-associated diseases. Front Cell Dev Biol. 2021;9:686548. https:\/\/doi.org\/10.3389\/fcell.2021.686548.","journal-title":"Front Cell Dev Biol"},{"issue":"3","key":"4310_CR52","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.immuni.2019.02.013","volume":"50","author":"AN Mathur","year":"2019","unstructured":"Mathur AN, Zirak B, Boothby IC, Tan M, Cohen JN, Mauro TM, et al. Treg-cell control of a CXCL5-IL-17 inflammatory axis promotes hair-follicle-stem-cell differentiation during skin-barrier repair. Immunity. 2019;50(3):655-667.e4. https:\/\/doi.org\/10.1016\/j.immuni.2019.02.013.","journal-title":"Immunity"},{"issue":"29","key":"4310_CR53","doi-asserted-by":"publisher","first-page":"14927","DOI":"10.1074\/jbc.M115.708446","volume":"291","author":"LD Towner","year":"2016","unstructured":"Towner LD, Wheat RA, Hughes TR, Morgan BP. Complement membrane attack and tumorigenesis. J Biol Chem. 2016;291(29):14927\u201338. https:\/\/doi.org\/10.1074\/jbc.M115.708446.","journal-title":"J Biol Chem"},{"issue":"3","key":"4310_CR54","doi-asserted-by":"publisher","DOI":"10.3390\/cells8030203","volume":"8","author":"J Kryczka","year":"2019","unstructured":"Kryczka J, Papiewska-Pajak I, Kowalska MA, Boncela J. Cathepsin B is upregulated and mediates ECM degradation in colon adenocarcinoma HT29 cells overexpressing Snail. Cells. 2019;8(3):203. https:\/\/doi.org\/10.3390\/cells8030203.","journal-title":"Cells"},{"key":"4310_CR55","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.matbio.2015.03.005","volume":"44\u201346","author":"V Arpino","year":"2015","unstructured":"Arpino V, Brock M, Gill SE. The role of TIMPs in regulation of extracellular matrix proteolysis. Matrix Biol. 2015;44\u201346:247\u201354. https:\/\/doi.org\/10.1016\/j.matbio.2015.03.005.","journal-title":"Matrix Biol"},{"issue":"1","key":"4310_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20307-9","volume":"12","author":"R Yabe","year":"2021","unstructured":"Yabe R, Chung SH, Murayama MA, Kubo S, Shimizu K, Akahori Y, et al. TARM1 contributes to development of arthritis by activating dendritic cells through recognition of collagens. Nat Commun. 2021;12(1):94. https:\/\/doi.org\/10.1038\/s41467-020-20307-9.","journal-title":"Nat Commun"},{"key":"4310_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2024.102031","volume":"46","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Zhang C, Chen G, You H, Wang S, Wang X, et al. Subclone from CT26 resistant to anti-PD-1 therapy associated with increased expression of genes related to glucocorticoids. Transl Oncol. 2024;46:102031. https:\/\/doi.org\/10.1016\/j.tranon.2024.102031.","journal-title":"Transl Oncol"},{"key":"4310_CR58","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1487296","volume":"16","author":"MM Abreu","year":"2025","unstructured":"Abreu MM, Chocron AF, Smadja DM. From cold to hot: mechanisms of hyperthermia in modulating tumor immunology for enhanced immunotherapy. Front Immunol. 2025;16:1487296. https:\/\/doi.org\/10.3389\/fimmu.2025.1487296.","journal-title":"Front Immunol"},{"key":"4310_CR59","doi-asserted-by":"publisher","DOI":"10.1177\/15347354241242094","volume":"23","author":"S Luk\u00e1csi","year":"2024","unstructured":"Luk\u00e1csi S, Munk\u00e1csy G, Gy\u0151rffy B. Harnessing hyperthermia: molecular, cellular, and immunological insights for enhanced anticancer therapies. Integr Cancer Ther. 2024;23:15347354241242094. https:\/\/doi.org\/10.1177\/15347354241242094.","journal-title":"Integr Cancer Ther"},{"issue":"10","key":"4310_CR60","doi-asserted-by":"publisher","first-page":"218","DOI":"10.20517\/2394-4722.2017.35","volume":"3","author":"Y Yagawa","year":"2017","unstructured":"Yagawa Y, Tanigawa K, Kobayashi Y, Yamamoto M. Cancer immunity and therapy using hyperthermia with immunotherapy, radiotherapy, chemotherapy, and surgery. JCMT. 2017;3(10):218. https:\/\/doi.org\/10.20517\/2394-4722.2017.35.","journal-title":"JCMT"},{"key":"4310_CR61","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1608555113","author":"S Wang","year":"2016","unstructured":"Wang S, Campos J, Gallotta M, Gong M, Crain C, Naik E, et al. Intratumoral injection of a CpG oligonucleotide reverts resistance to PD-1 blockade by expanding multifunctional CD8+ T cells. Proc Natl Acad Sci U S A. 2016. https:\/\/doi.org\/10.1073\/pnas.1608555113.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"20","key":"4310_CR62","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.160063","volume":"7","author":"T Jiang","year":"2022","unstructured":"Jiang T, Zhang H, Li Y, Jayakumar P, Liao H, Huang H, et al. Intraperitoneal injection of class A TLR9 agonist enhances anti-PD-1 immunotherapy in colorectal peritoneal metastases. JCI Insight. 2022;7(20):e160063. https:\/\/doi.org\/10.1172\/jci.insight.160063.","journal-title":"JCI Insight"},{"issue":"2","key":"4310_CR63","doi-asserted-by":"publisher","first-page":"34","DOI":"10.32607\/20758251-2011-3-2-34-55","volume":"3","author":"LA Dykman","year":"2011","unstructured":"Dykman LA, Khlebtsov NG. Gold nanoparticles in biology and medicine: recent advances and prospects. Acta Nat. 2011;3(2):34\u201355 (PubMed PMID: 22649683; PubMed Central PMCID: PMC3347577).","journal-title":"Acta Nat"},{"key":"4310_CR64","doi-asserted-by":"publisher","DOI":"10.34133\/bmr.0024","volume":"28","author":"WS Yun","year":"2024","unstructured":"Yun WS, Yang W, Shim MK, Song S, Choi J, Kim J, et al. Accurately controlled tumor temperature with silica-coated gold nanorods for optimal immune checkpoint blockade therapy. Biomater Res. 2024;28:0024. https:\/\/doi.org\/10.34133\/bmr.0024.","journal-title":"Biomater Res"},{"issue":"32","key":"4310_CR65","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202309495","volume":"20","author":"N Farivar","year":"2024","unstructured":"Farivar N, Khazamipour N, Roberts ME, Nelepcu I, Marzban M, Moeen A, et al. Pulsed photothermal therapy of solid tumors as a precondition for immunotherapy. Small. 2024;20(32):2309495. https:\/\/doi.org\/10.1002\/smll.202309495.","journal-title":"Small"},{"issue":"3","key":"4310_CR66","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/s41416-023-02537-y","volume":"130","author":"HH Hsieh","year":"2024","unstructured":"Hsieh HH, Chen CL, Chan HW, Chi KH, Wu CY. Enhanced antitumour response of gold nanostar-mediated photothermal therapy in combination with immunotherapy in a mouse model of colon carcinoma. Br J Cancer. 2024;130(3):406\u201316. https:\/\/doi.org\/10.1038\/s41416-023-02537-y.","journal-title":"Br J Cancer"},{"issue":"1","key":"4310_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/srep11398","volume":"5","author":"J Wan","year":"2015","unstructured":"Wan J, Wang JH, Liu T, Xie Z, Yu XF, Li W. Surface chemistry but not aspect ratio mediates the biological toxicity of gold nanorods in vitro and in vivo. Sci Rep. 2015;5(1):11398. https:\/\/doi.org\/10.1038\/srep11398.","journal-title":"Sci Rep"},{"issue":"3","key":"4310_CR68","doi-asserted-by":"publisher","DOI":"10.1002\/adtp.202400347","volume":"8","author":"J Buiel","year":"2025","unstructured":"Buiel J, Robert J, Mekhjian D, Chauhan DS, Banquy X. Photothermal therapy: from encouraging lab results to lackluster clinical translation. Adv Ther. 2025;8(3):2400347. https:\/\/doi.org\/10.1002\/adtp.202400347.","journal-title":"Adv Ther"},{"issue":"37","key":"4310_CR69","doi-asserted-by":"publisher","first-page":"18590","DOI":"10.1073\/pnas.1906929116","volume":"116","author":"AR Rastinehad","year":"2019","unstructured":"Rastinehad AR, Anastos H, Wajswol E, Winoker JS, Sfakianos JP, Doppalapudi SK, et al. Gold nanoshell-localized photothermal ablation of prostate tumors in a clinical pilot device study. Proc Natl Acad Sci U S A. 2019;116(37):18590\u20136. https:\/\/doi.org\/10.1073\/pnas.1906929116.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"4310_CR70","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1177\/1091581815600170","volume":"35","author":"JM Stern","year":"2016","unstructured":"Stern JM, Kibanov Solomonov VV, Sazykina E, Schwartz JA, Gad SC, Goodrich GP. Initial evaluation of the safety of nanoshell-directed photothermal therapy in the treatment of prostate disease. Int J Toxicol. 2016;35(1):38\u201346. https:\/\/doi.org\/10.1177\/1091581815600170.","journal-title":"Int J Toxicol"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04310-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04310-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04310-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,24]],"date-time":"2026-05-24T23:25:56Z","timestamp":1779665156000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-026-04310-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,6]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4310"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04310-8","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,6]]},"assertion":[{"value":"5 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal study was approved by the University Committee on Laboratory Animals at Dalhousie University and the Canadian Council on Animal Care. The study was conducted in accordance with the local legislation and institutional requirements.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"CAG is Chief Medical Director for Sona Nanotech Inc.\n                      \u2122\n                      . The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"450"}}